In esophageal squamous cell carcinoma (ESCC), the effect of 5-fluorouracil was completely different: in this case, the chemotherapeutic agent induced activation of Erk and Akt in ESCC cells, both in vivo and in vitro. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.